Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Aesthetic Medicine Symposium - September 18-21 in Scottsdale, AZ! Secure Your Spot

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

Evidence-Based Training100% Online & Self-PacedAbout 3 Hours

Peptide Therapy Certification for Providers

Your patients are asking about peptides faster than most practices can get trained to answer. Build an evidence-based framework to evaluate, prescribe, and monitor peptide therapies across metabolic, growth hormone, and regenerative categories.

Regular price $595

$295

You save $300 through August 31
Enroll Now — $295 →

7-Day Money-Back Guarantee  |  100% Online & Self-Paced  |  About 3 Hours to Complete

By the End of This Course, You Will Be Able To:

Evaluate peptide therapy with a clinical framework — not a protocol list.

01

Differentiate peptide classes and mechanisms

Understand receptor binding, gene expression modulation, and downstream signaling pathways across metabolic, growth hormone, and regenerative peptides.

02

Distinguish product categories

Separate FDA-approved, compounded, and investigational products, including current 503A/503B sourcing rules and the status of AOD-9604, Melanotan II, and Epithalon.

03

Select and monitor patients

Apply comprehensive history, contraindications, IGF-1 interpretation, and a monitoring schedule tied to each therapy.

04

Counsel on GLP-1 and dual agents

Differentiate semaglutide, tirzepatide, and liraglutide by mechanism, labeled indication, and administration pattern.

05

Apply consent and documentation standards

Use standards built for compounded and investigational peptides, including WADA restrictions where relevant.

06

Build a compliant practice framework

Implement sourcing verification, cash-pay economics, and FDA/FTC-compliant marketing.

Why This Course

Patients are arriving with questions. You need an evidence-based way to answer them.

Peptide therapy is expanding faster than most providers received formal training for it. Patients are arriving with information from social media and direct-to-consumer marketing — often without the clinical context to separate an FDA-approved therapy from a research-use-only compound being sold online. This course closes that gap with a structured, evidence-based curriculum instead of a protocol list.

What’s Included in the Course

Seven modules built around clinical decision-making.

Not dosing charts alone. Each module builds the knowledge, context, and practice framework needed to evaluate peptide therapies responsibly.

01

Foundations

What peptides are, mechanisms of action, pharmacokinetics and half-life, routes of administration, and the three regulatory categories every provider needs to recognize: FDA-approved, compounded, and investigational/unapproved. Includes a full clinical case study walking through patient evaluation before initiating therapy.

02

Metabolic Peptides

GLP-1 and dual GIP/GLP-1 receptor agonism explained at the mechanism level, then applied product by product: semaglutide, tirzepatide, and liraglutide — indication, route, and dosing pattern differentiated so you’re not treating them as interchangeable. Covers pre-treatment evaluation, tolerability, follow-up, and the AOD-9604 investigational pipeline. Includes a dedicated section on current GLP-1 compounding rules under 503A and 503B following the resolution of national shortages.

03

Growth Hormone Secretagogues

Physiology of the growth hormone axis, then an agent-by-agent review: sermorelin, tesamorelin, CJC-1295 with and without DAC, ipamorelin, MK-677/ibutamoren, and GHRP-2/GHRP-6. Covers the CJC-1295 + ipamorelin combination, dosing and cycling considerations, IGF-1 interpretation, and a monitoring schedule for ongoing therapy.

04

Regenerative Peptides

BPC-157 (oral vs. injectable, proposed mechanisms, current evidence and regulatory status), the BPC-157 + TB-500 combination, and GHK-Cu — including where gut-healing and regenerative claims outpace the current evidence base.

05

Practice Framework

503A/503B sourcing verification, recognizing RUO and gray-market red flags, consultation pricing and cash-pay models, FDA/FTC-compliant marketing, drug-drug interactions, adverse event reporting, and informed consent requirements built specifically for peptide therapy.

06

Regulatory Appendix

A peptide-by-peptide regulatory reference, current GLP-1 compounding updates, and PCAC classification changes — built as a resource you return to, not just a one-time read.

07

Conclusion

Key clinical takeaways and a consolidated educational disclaimer for your records.

Is This Course Right for You?

Build a responsible peptide-therapy foundation — with clear expectations.

This course is designed to help the right providers move from patient questions to a structured clinical framework, while being clear about what self-paced education can and cannot provide.

This Course Is For

Providers Building a Thoughtful Practice Framework

A strong fit for clinicians evaluating whether peptide therapy belongs in a metabolic, regenerative, or wellness-focused practice.

Physicians (MDs and DOs), nurse practitioners, physician assistants, registered nurses, and pharmacists.
Integrative and functional medicine practitioners.
Any provider evaluating whether to add peptide therapy to a metabolic, regenerative, or wellness-focused practice.

Set Expectations Before You Enroll

What This Course Does Not Promise

This is evidence-based, self-paced education. It gives you a framework for clinical decision-making; it does not remove professional responsibility.

It is not a dosing-table shortcut. It requires engaging with mechanism, evidence, and regulatory nuance, not just memorizing protocols.
It is not hands-on procedural training.
It is not a substitute for verifying current FDA guidance before prescribing; regulatory classifications for peptides are actively evolving.

Course Details

One-time payment. Practical reference value for 12 months.

Seven-module curriculum covering metabolic, growth hormone, and regenerative peptides
About 3 hours to complete
Full clinical case study with guided discussion
Regulatory reference appendix for ongoing use
12-month access and certificate of completion
One-time payment, no subscription; 100% online and self-paced
IAPAM

Faculty

Built for clinical decision-making.

Course content was developed for healthcare professionals evaluating peptide therapy across endocrinology, obesity medicine, regenerative medicine, sports medicine, and aesthetic practice, with emphasis on evidence-based clinical decision-making, responsible prescribing, and regulatory compliance.

Faculty bio / credentials — confirm before publishing.

Frequently Asked Questions

Before You Enroll

Do I need prior experience with peptide therapy to enroll?
No. The course builds from foundational pharmacology through practice-level implementation.
How long will the course take to complete?
About 3 hours, self-paced.
How long do I have access?
12 months from enrollment.
Is this entirely online?
Yes, 100% online and self-paced.
Who can enroll?
Physicians, nurse practitioners, physician assistants, registered nurses, pharmacists, and integrative/functional medicine practitioners.
Does this course cover compounded and investigational peptides, or only FDA-approved ones?
All three categories, with dedicated attention to what separates them — a distinction the course treats as central to responsible prescribing, not a footnote.
What’s your guarantee?
A 7-day money-back guarantee. To qualify, you must not have completed more than 20% of the course, and you must not have downloaded your certificate of completion.

Ready to Get Started?

Bring an evidence-based peptide framework into your practice.

Get the clinical context, regulatory perspective, and ongoing reference tools to answer patient questions with greater clarity.

Enroll Now — $295 →

Educational Disclaimer

This educational activity is intended solely for educational purposes and should not be interpreted as medical, legal, regulatory, or prescribing advice. Healthcare providers remain responsible for exercising independent clinical judgment and complying with all applicable regulations, standards of care, and professional requirements. Regulatory classifications for peptides are actively evolving; always verify current FDA guidance before prescribing.